{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-009813","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.896093+00:00","generated_at":"2026-05-15T09:08:49.198425+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioLargo enters $10M equity purchase agreement with Clearthink Capital Partners","bullets":["Clearthink commits to buy up to $10M of BioLargo common stock over 36 months under a Strata purchase agreement.","Draws limited to $500K per notice; pricing equals avg of two lowest closing prices in prior 8 trading days; min $25K.","BioLargo issued 500,000 commitment shares to Clearthink as consideration; no cash proceeds from those shares.","Clearthink prohibited from short selling or hedging during term; beneficial ownership capped at 9.99%.","Proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-009813","json":"https://secwatch.observer/filing/0001437749-26-009813.json","markdown":"https://secwatch.observer/filing/0001437749-26-009813.md","text":"https://secwatch.observer/filing/0001437749-26-009813.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774926009813/0001437749-26-009813-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774926009813/blgo20260319_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:08:49.198425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d329b1b22916c2d724db1cec802fbe908407b09b","claim":"BIOLARGO, INC. entered into Purchase Agreement with CLEARTHINK CAPITAL PARTNERS, LLC valued at up to $10.0 million (effective 2026-03-20).","evidence_excerpt":"On March 20, 2026, BioLargo, Inc. (the “Company” or “we”) entered into a purchase agreement dated as of March 20, 2026 (the “Purchase Agreement”), and a registration rights agreement dated as of March 20, 2026 (the “Registration Rights Agreement”), with CLEARTHINK CAPITAL PARTNERS, LLC (“Clearthink”), pursuant to which Clearthink has committed to purchase up to $10.0 million of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/880242/000143774926009813/0001437749-26-009813-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"CLEARTHINK CAPITAL PARTNERS, LLC"},{"label":"Value","value":"up to $10.0 million"},{"label":"Effective","value":"2026-03-20"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}